Charles V. Baltic III, Director at MEI Pharma, Inc. (MEIP), bought 2,600 shares at $6.82 ($18K) on 2013-08-16, disclosed to the SEC on 2013-08-20.
Open-market purchase of $18k MEIP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.82 | 1,200 | $8K | 46.2% |
| 2 | $6.82 | 1,400 | $10K | 53.8% |
| Total | $6.82 avg | 2,600 | $18K | 100% |
| Filing → |
| MEIP | SELL | 2017-11-29 | $24K | — | Filing → |
| MEIP | BUY | 2015-01-23 | $19K | — | Filing → |
| MEIP | BUY | 2015-01-02 | $13K | — | Filing → |